Top Markets
#1 0G 0G +27.23%
#2 SAFEcoin SAFEcoin +22.07%
#3 Cysic Cysic +21.21%
#4 Axelar Axelar +20.27%
#5 Zora Zora +19.14%
#6 Full Moon Full Moon +18.76%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.39%
#8 AI XOVIA AI XOVIA +16.31%
#9 StonkBroker StonkBroker +15.74%
#10 VVS Finance VVS Finance +14.74%
Coin of the day
0G 0G
設定
言語
日本
通貨
USD
テーマ
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
株式のランク #12973
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
株価
$0.66137861
時価総額
$531.70M
変化（1日）
-2.45%
変化（1年）
-42.12%
国
CN
取引 Ocumension Therapeutics (1477)

カテゴリー

Healthcare
Ocumension Therapeutics（1477）のEPS
2026 時点のEPS TTM: 0
Ocumension Therapeuticsの最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Ocumension TherapeuticsのEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH